Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03601819
Title Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Michigan Rogel Cancer Center
Indications

peripheral T-cell lymphoma

primary cutaneous T-cell non-Hodgkin lymphoma

splenic marginal zone lymphoma

lymphoplasmacytic lymphoma

mantle cell lymphoma

chronic lymphocytic leukemia

Therapies

Pacritinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST